文献速递脑血管病癫痫

青年缺血性卒中或脑出血后卒中后癫痫风险

Risk of Poststroke Epilepsy Among Young Adults With Ischemic Stroke or Intracerebral Hemorrhage.
PubMed 文献 · JAMA Neurol · 2025-01-01

该队列研究纳入1388例18至49岁首次影像学确诊的缺血性卒中或脑出血患者,随访中位5.3年,4.1%发生卒中后癫痫。缺血性卒中后5年累积风险为3.7%,脑出血后为7.6%;急性症状性发作和皮层受累与缺血性卒中后癫痫相关,皮层受累与脑出血后癫痫相关。SeLECT 2.0和CAVE风险评分在青年人群中区分度良好且校准良好。

要点

  • 青年卒中后癫痫5年累积风险缺血性卒中3.7%、脑出血7.6%。
  • 缺血性卒中后癫痫相关因素:急性症状性发作(HR 10.83)和皮层受累(HR 5.35)。
  • 脑出血后癫痫仅皮层受累相关(HR 8.20);SeLECT 2.0和CAVE评分适用。

核心结论

  • 青年成人卒中后癫痫风险相对较低,相关因素与现有风险评分包含的变量相似,现有评分可用于青年卒中后患者。

研究设计与样本

  • 前瞻性队列研究(ODYSSEY),荷兰17家医院,2013年5月27日至2021年3月3日纳入,随访至2024年2月28日。
  • 纳入1388例18至49岁、影像学确诊的首次缺血性卒中或脑出血且无癫痫史的患者;中位年龄44.1岁,男性736例(53.0%),中位随访5.3年。

主要发现

  • 57例(4.1%)发生卒中后癫痫;缺血性卒中后5年累积风险3.7%(95% CI 0.2%-4.8%),脑出血后7.6%(95% CI 3.5%-11.8%)。
  • SeLECT 2.0评分C统计量0.78(95% CI 0.71-0.84),CAVE评分C统计量0.83(95% CI 0.76-0.90),两者校准良好。

临床怎么用

  • 现有SeLECT 2.0(缺血性卒中)和CAVE(脑出血)风险评分可用于青年卒中后患者进行卒中后癫痫风险分层。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Poststroke epilepsy (PSE) is a major complication among young adults and is associated with problems with functional recovery and daily life. Although scores have been developed to predict risk of PSE, they have not been validated among patients with stroke at a young age. OBJECTIVES: To investigate both the risk of and risk factors for PSE at a young age and validate current PSE risk scores among a cohort of young adults. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from ODYSSEY (Observational Dutch Young Symptomatic Stroke Study), a prospective cohort study conducted among 17 hospitals in the Netherlands between May 27, 2013, and March 3, 2021, with follow-up until February 28, 2024. Participants included 1388 consecutive patients aged 18 to 49 years with neuroimaging-proven ischemic stroke or intracerebral hemorrhage (ICH) and without a history of epilepsy. Statistical analysis took place between June and August 2024. EXPOSURE: First-ever neuroimaging-proven ischemic stroke or ICH. MAIN OUTCOMES AND MEASURES: Poststroke epilepsy was defined as at least 1 remote symptomatic seizure (>7 days). Cumulative incidence functions were used to calculate the 5-year risk of PSE. Fine-Gray regression models were used to identify risk factors associated with PSE (age, sex, clinical stroke, and neuroimaging variables). The performances of the SeLECT (severity of stroke, large-artery atherosclerosis, early seizure, cortical involvement, and territory of middle cerebral artery) 2.0 risk score (for ischemic stroke) and the CAVE (cortical involvement, age, bleeding volume, and early seizure) risk score (for ICH) were assessed with C statistics and calibration bar plots. RESULTS: This study included 1388 patients (ischemic stroke, 1231 [88.7%]; ICH, 157 [11.3%]; median age, 44.1 years [IQR, 38.0-47.4 years]; 736 men [53.0%]; median follow-up, 5.3 years [IQR, 3.4-7.4 years]), of whom 57 (4.1%) developed PSE. The 5-year cumulative risk of PSE was 3.7% (95% CI, 0.2%-4.8%) after ischemic stroke and 7.6% (95% CI, 3.5%-11.8%) after ICH. Factors associated with PSE after ischemic stroke were an acute symptomatic seizure (<7 days) (hazard ratio [HR], 10.83 [95% CI, 2.05-57.07]; P = .005) and cortical involvement (HR, 5.35 [95% CI, 1.85-15.49]; P = .002). The only factor associated with PSE after ICH was cortical involvement (HR, 8.20 [95% CI, 2.22-30.25]; P = .002). The C statistic was 0.78 (95% CI, 0.71-0.84) for the SeLECT 2.0 risk score and 0.83 (95% CI, 0.76-0.90) for the CAVE risk score, and calibration was good for both scores. CONCLUSION: This study suggests that the risk of PSE among young adults is relatively low and that the factors that were associated with PSE were similar to variables included in the existing risk scores, which can therefore also be applied for young adults after stroke. Future clinical trials should investigate the optimal primary and secondary prophylaxis for patients at high risk.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Verburgt E, Fellah L, Ekker MS, et al. Risk of Poststroke Epilepsy Among Young Adults With Ischemic Stroke or Intracerebral Hemorrhage. JAMA Neurol. 2025. PMID: 40227717. doi:10.1001/jamaneurol.2025.0465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。